Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brit Mollenhauer

Showing results (171-180 of 304) with videos related to

Pageof 31
Sort By:
International Journal of Methods in Psychiatric Research|April 19, 2017
Psychometric properties of the apathy evaluation scale in patients with Parkinson's diseaseUlrike Lueken, Ricarda Evens, Monika Balzer-Geldsetzer, et al.
Experimental Neurology|July 16, 2008
Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegenerationBrit Mollenhauer, Valerie Cullen, Ilana Kahn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 2012
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesIrene Litvan, Jennifer G Goldman, Alexander I Tröster, et al.
JAMA Neurology|November 22, 2021
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy BodiesMaria C Gonzalez, Nicholas J Ashton, Bárbara Fernandes Gomes, et al.
Parkinsonism & Related Disorders|August 21, 2021
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyRobert Lillig, Anja Ophey, Jörg B Schulz, et al.
Plos One|January 4, 2014
Niemann-Pick C disease gene mutations and age-related neurodegenerative disordersMichael Zech, Georg Nübling, Florian Castrop, et al.
Nature|February 22, 2019
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degenerationDmitri Lodygin, Moritz Hermann, Nils Schweingruber, et al.
Journal of Parkinson'S Disease|September 25, 2018
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)Lana M Chahine, Thomas G Beach, Nicholas Seedorff, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 8, 2018
Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)Yuliya Stankevich, Ulrike Lueken, Monika Balzer-Geldsetzer, et al.
Autophagy|December 5, 2017
Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotypeGeorgia Minakaki, Stefanie Menges, Agnes Kittel, et al.
Pageof 31

Showing results (171-180 of 304) with videos related to

Sort By:
Pageof 31
International Journal of Methods in Psychiatric Research|April 19, 2017
Psychometric properties of the apathy evaluation scale in patients with Parkinson's diseaseUlrike Lueken, Ricarda Evens, Monika Balzer-Geldsetzer, et al.
Experimental Neurology|July 16, 2008
Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegenerationBrit Mollenhauer, Valerie Cullen, Ilana Kahn, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 26, 2012
Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesIrene Litvan, Jennifer G Goldman, Alexander I Tröster, et al.
JAMA Neurology|November 22, 2021
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy BodiesMaria C Gonzalez, Nicholas J Ashton, Bárbara Fernandes Gomes, et al.
Parkinsonism & Related Disorders|August 21, 2021
A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic "CERAD-Plus" tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE studyRobert Lillig, Anja Ophey, Jörg B Schulz, et al.
Plos One|January 4, 2014
Niemann-Pick C disease gene mutations and age-related neurodegenerative disordersMichael Zech, Georg Nübling, Florian Castrop, et al.
Nature|February 22, 2019
β-Synuclein-reactive T cells induce autoimmune CNS grey matter degenerationDmitri Lodygin, Moritz Hermann, Nils Schweingruber, et al.
Journal of Parkinson'S Disease|September 25, 2018
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4)Lana M Chahine, Thomas G Beach, Nicholas Seedorff, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|August 8, 2018
Psychometric Properties of an Abbreviated Version of the Apathy Evaluation Scale for Parkinson Disease (AES-12PD)Yuliya Stankevich, Ulrike Lueken, Monika Balzer-Geldsetzer, et al.
Autophagy|December 5, 2017
Autophagy inhibition promotes SNCA/alpha-synuclein release and transfer via extracellular vesicles with a hybrid autophagosome-exosome-like phenotypeGeorgia Minakaki, Stefanie Menges, Agnes Kittel, et al.
Pageof 31